Sarcomas of the head and neck

Surgical Oncology Clinics of North America

Volumn 12, Issue 2, 2003, Pages 379-417

  Potter, Bryan O ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ALVEOLAR SOFT PART SARCOMA; ANGIOSARCOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CHONDROSARCOMA; CLINICAL TRIAL; CYTOGENETICS; EWING SARCOMA; FIBROSARCOMA; HEAD AND NECK CANCER; HEMANGIOPERICYTOMA; HISTIOCYTOMA; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MEDICAL DECISION MAKING; META ANALYSIS; METASTASIS; NEUROFIBROSARCOMA; ORBIT CANCER; OSTEOSARCOMA; PARANASAL SINUS CANCER; PLASTIC SURGERY; PROGNOSIS; QUALITY OF LIFE; REHABILITATION; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; SYNOVIAL SARCOMA; TUMOR VOLUME;

EID: 0038076231     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00005-X     Document Type: Review

References (183)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
2. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999; 49:8-31.
3. Lawrence W Jr, Anderson JR, Gehan EA, et al. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Cancer 1997;80:1165-70.
4. Weber RS, Benjamin RS, Peters LJ, et al. Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 1986;152:386-92.
5. Kraus DH, Dubner S, Harrison LB, et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994;74:697-702.
6. Wanebo HJ, Koness RJ, MacFarlane JK, et al. Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 1992;14:1-7.
7. Lyos AT, Goepfert H, Luna MA, et al. Soft tissue sarcoma of the head and neck in children and adolescents. Cancer 1996;77:193-200.
8. Farhood AI, Hajdu SI, Shiu MH, et al. Soft tissue sarcomas of the head and neck in adults. Am J Surg 1990;160:365-9.
9. Lawrence W Jr. Operative management of soft tissue sarcomas: impact of anatomic site. Semin Surg Oncol 1994;10:340-6.
10. Laskin WB. Dermatofibrosarcoma protuberans. CA Cancer J Clin 1992;42:116-25.
11. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
12. Zahm SH, Fraumeni JF Jr. The epidemiology of soft tissue sarcoma. Semin Oncol 1997;24:504-14.
13. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
14. Viskochil D, White R, Cawthon R. The neurofibromatosis type 1 gene. Annu Rev Neurosci 1993;16:183-205.
15. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. National Cancer Institute Monographs 1985;68:99-112.
16. Mark RJ, Poen J, Tran LM, et al. Postirradiation sarcomas: a single-institution study and review of the literature. Cancer 1994;73:2653-62.
17. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992;23:915-23.
18. Taghian A, de Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991;21:361-7.
19. Mark RJ, Bailet JW, Poen J, et al. Postirradiation sarcoma of the head and neck. Cancer 1993;72:887-93.
20. Ko JY, Chen CL, Lui LT, et al. Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996; 122:535-8.
21. McKillop JH, Doig JA, Kennedy JS, et al. Laryngeal malignancy following iodine-125 therapy for thyrotoxicosis. Lancet 1978;2:1177-9.
22. Tynes T, Andersen A, Langmark F. Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. Am J Epidemiol 1992;136:81-8.
23. Popper H, Thomas LB, Telles NC, et al. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic: comparison with cases of unknown etiology. Am J Pathol 1978;92:349-69.
24. Grufferman S, Schwartz AG, Ruymann FB, et al. Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 1993;4:217-24.
25. Zahm SH, Blair A, Holmes FF, et al. A case-control study of soft-tissue sarcoma. Am J Epidemiol 1989;130:665-74.
26. Zahm SH, Heineman EF, Vaught JB. Soft tissue sarcoma and tobacco use: data from a prospective cohort study of United States veterans. Cancer Causes Control 1992;3:371-6.
27. Patel SC, Silbergleit R, Talati SJ. Sarcomas of the head and neck. Top Magn Reson Imaging 1999;10:362-75.
28. Arca MJ, Sondak VK, Chang AE. Diagnostic procedures and pretreatment evaluation of soft tissue sarcomas. Semin Surg Oncol 1994;10:323-31.
29. Brennan MF. The surgeon as a leader in cancer care: lessons learned from the study of soft tissue sarcoma. J Am Coll Surg 1996;182:520-9.
30. Goepfert H, Raymond K, Spires JR, et al. Osteosarcoma of the head and neck. Cancer Bull 1990;42:347-54.
31. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2002;20:776-790.
32. Ha PK, Eisele DW, Frassica FJ, et al. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope 1999;109:964-9.
33. Mark RJ, Sercarz JA, Tran L, et al. Osteogenic sarcoma of the head and neck: the UCLA experience. Arch Otolaryngol Head Neck Surg 1991;117:761-6.
34. Daw NC, Mahmoud HH, Meyer WH, et al. Bone sarcomas of the head and neck in children: the St. Jude Children's Research Hospital experience. Cancer 2000;88:2172-80.
35. Gadwal SR, Gannon FH, Fanburg-Smith JC, et al. Primary osteosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 22 cases with a review of the literature. Cancer 2001;91:598-605.
36. Clark JL, Unni KK, Dahlin DC, et al. Osteosarcoma of the jaw. Cancer 1983;51:2311-6.
37. Hoffman S. Intraosseous and paraosteal tumors of the jaws. In: Hoffman S, Jacoury JR, Krolls S, editors. Atlas of tumor pathology. 2nd edition. Washington, DC: Air Force Institute of Pathology; 1987. p. 170-80.
38. Lewis M, Perl A, Som PM, et al. Osteogenic sarcoma of the jaw: a clinicopathologic review of 12 patients. Arch Otolaryngol Head Neck Surg 1997;123:169-74.
39. Inwards CY, Unni KK. Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 1995;9:545-69.
40. Chan CW, Kung TM, Ma L. Telangiectatic osteosarcoma of the mandible. Cancer 1986; 58:2110-5.
41. Roca AN, Smith JL Jr, Jing BS. Osteosarcoma and parosteal osteogenic sarcoma of the maxilla and mandible: study of 20 cases. Am J Clin Pathol 1970;54:625-36.
42. Kassir RR, Rassekh CH, Kinsella JB, et al. Osteosarcoma of the head and neck: metaanalysis of nonrandomized studies. Laryngoscope 1997;107:56-61.
43. Oda D, Bavisotto LM, Schmidt RA, et al. Head and neck osteosarcoma at the University of Washington. Head Neck 1997;19:513-23.
44. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in osteosarcoma: basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am 1995;9:825-40.
45. Gorsky M, Epstein JB. Craniofacial osseous and chondromatous sarcomas in British Columbia - a review of 34 cases. Oral Oncol 2000;36:27-31.
46. Akbiyik N, Alexander LL. Osteosarcoma of the maxilla treated with radiation therapy and surgery. J Natl Med Assoc 1981;73:355-6.
47. Smeele LE, Kostense PJ, van der Waal I, et al. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 1997; 15:363-7.
48. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp: prognosis and treatment. Cancer 1987;59:1046-57.
49. Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. Am J Surg 1994;168:451-4.
50. Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer 1981:48:1907-21.
51. Aust MR, Olsen KD, Lewis JE, et al. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol 1997;106:943-51.
52. Mark RJ, Tran LM, Sercarz J, et al. Angiosarcoma of the head and neck: the UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993;119:973-8.
53. Morrison WH, Byers RM, Garden AS, et al. Cutaneous angiosarcoma of the head and neck: a therapeutic dilemma. Cancer 1995;76:319-27.
54. Panje WR, Moran WJ, Bostwick DG, et al. Angiosarcoma of the head and neck: review of 11 cases. Laryngoscope 1986;96:1381-4.
55. Loudon JA, Billy ML, DeYoung BR, et al. Angiosarcoma of the mandible: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:471-6.
56. Kraus D, Harrison L, O'Malley B. Soft tissue and bone sarcomas of the head and neck. In: Harrison LB, Sessions RB, Hong WK, editors. Head and neck cancer, a multidisciplinary approach. Philadelphia: Lippincott-Raven; 1999. p. 871-95.
57. Loos BM, Wieneke JA, Thompson LD. Laryngeal angiosarcoma: a clinicopathologic study of five cases with a review of the literature. Laryngoscope 2001;111:1197-202.
58. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996;77:2400-6.
59. Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 1996;61:170-6.
60. Amato L, Moretti S, Palleschi GM, et al. A case of angiosarcoma of the face successfully treated with combined chemotherapy and radiotherapy. Br J Dermatol 2000;142:822-4.
61. Wollina U, Fuller J, Graefe T, et al. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol 2001;127:396-9.
62. Ulrich L, Krause M, Brachmann A, et al. Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereol 2000;14:412-5.
63. Enzinger FM. Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol 1986;10(Suppl):43-53.
64. Fagundes HM, Lai PP, Dehner LP, et al. Postoperative radiotherapy for malignant fibrous histiocytoma. Int J Radiat Oncol Biol Phys 1992;23:615-9.
65. Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am J Surg Pathol 1985;9:853-71.
66. LeVay J, O'Sullivan B, Catton C, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993;27:1091-9.
67. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978;41:2250-66.
68. Blitzer A, Lawson W, Zak FG, et al. Clinical-pathological determinants in prognosis of fibrous histiocytomas of head and neck. Laryngoscope 1981;91:2053-70.
69. Abdul-Karim FW, Ayala AG, Chawla SP, et al. Malignant fibrous histiocytoma of jaws. A clinicopathologic study of 11 cases. Cancer 1985;56:1590-6.
70. Barnes L, Kanbour A. Malignant fibrous histiocytoma of the head and neck. A report of 12 cases. Arch Otolaryngol Head Neck Surg 1988;114:1149-56.
71. Fell W, Housini I, Marple B. Radiation-induced malignant fibrous histiocytoma of the head and neck. Otolaryngol Head Neck Surg 1998;118:529-31.
72. Ferlito A, Nicolai P, Recher G, et al. Primary laryngeal malignant fibrous histiocytoma: review of the literature and report of seven cases. Laryngoscope 1983;93:1351-8.
73. Lin SK, How SW, Wang JT, et al. Oral post-radiation malignant fibrous histiocytoma: a clinicopathological study. J Oral Pathol Med 1994;23:324-9.
74. Ogura JH, Toomey JM, Setzen M, et al. Malignant fibrous histiocytoma of the head and neck. Laryngoscope 1980;90:1429-40.
75. Singh B, Shaha A, Har-El G. Malignant fibrous histiocytoma of the head and neck. J Craniomaxillofac Surg 1993;21:262-5.
76. Frankenthaler R, Ayala AG, Hartwick RW, et al. Fibrosarcoma of the head and neck. Laryngoscope 1990;100:799-802.
77. Dei Tos AP, Dal Cin P. The role of cytogenetics in the classification of soft tissue tumours. Virchows Arch 1997;431:83-94.
78. Hibshoosh H, Lattes R. Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer. Semin Oncol 1997;24:515-25.
79. Ordonez NG. Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol 1998;5:67-85.
80. Lindberg RD, Martin RG, Romsdahl MM, et al. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer 1981;47:2391-7.
81. Reagan MT, Clowry LJ, Cox JD, et al. Radiation therapy in the treatment of malignant fibrous histiocytoma. Int J Radiat Oncol Biol Phys 1981;7:311-5.
82. Tran LM, Mark R, Meier R, et al. Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer 1992;70:169-77.
83. van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 1999;17:150-7.
84. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997;350:1647-54.
85. Freedman AM, Reiman HM, Woods JE. Soft-tissue sarcomas of the head and neck. Am J Surg 1989;158:367-72.
86. Callender TA, Weber RS, Janjan N, et al. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 1995;112:252-7.
87. el-Naggar AK, Batsakis JG, Ordonez NG, et al. Rhabdomyosarcoma of the adult head and neck: a clinicopathological and DNA ploidy study. J Laryngol Otol 1993;107:716-20.
88. Nayar RC, Prudhomme F, Parise O Jr, et al. Rhabdomyosarcoma of the head and neck in adults: a study of 26 patients. Laryngoscope 1993;103:1362-6.
89. La Quaglia MP, Heller G, Ghavimi F, et al. The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer 1994;73:109-17.
90. Le Vay J, O'Sullivan B, Catton C, et al. An assessment of prognostic factors in soft-tissue sarcoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:981-6.
91. Feldman BA. Rhabdomyosarcoma of the head and neck. Laryngoscope 1982;92:424-40.
92. Nakhleh RE, Swanson PE, Dehner LP. Juvenile (embryonal and alveolar) rhabdomyosarcoma of the head and neck in adults: a clinical, pathologic, and immunohistochemical study of 12 cases. Cancer 1991;67:1019-24.
93. Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist 1999;4:34-44.
94. Kraus DH, Saenz NC, Gollamudi S, et al. Pediatric rhabdomyosarcoma of the head and neck. Am J Surg 1997;174:556-60.
95. Anderson GJ, Tom LW, Womer RB, et al. Rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg 1990;116:428-31.
96. Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 2001;23:215-20.
97. Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2000;18:2427-34.
98. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-30.
99. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-102.
100. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I: a final report. Cancer 1988;61:209-20.
101. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.
102. Donaldson SS, Meza J, Breneman JC, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - a report from the IRSG. Int J Radiat Oncol Biol Phys 2001;51:718-28.
103. Paulino AC, Simon JH, Zhen W, et al. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2000;48:1489-95.
104. Rodary C, Gehan EA, Flamant F, et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 1991;19:89-95.
105. Bizer LS. Fibrosarcoma. Report of sixty-four cases. Am J Surg 1971;121:586-7.
106. Scott SM, Reiman HM, Pritchard DJ, et al. Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases. Cancer 1989;64:925-31.
107. Hollowood K, Fletcher CD. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol 1995;12:210-20.
108. van Unnik JA. Classification and grading of soft-tissue sarcomas. Hematol Oncol Clin North Am 1995;9:677-700.
109. Greager JA, Reichard K, Campana JP, et al. Fibrosarcoma of the head and neck. Am J Surg 1994;167:437-9.
110. Mark RJ, Sercarz JA, Tran L, et al. Fibrosarcoma of the head and neck: the UCLA experience. Arch Otolaryngol Head Neck Surg 1991;117:396-401.
111. Vandeweyer E, Seyeidi JV, Deraemaecker R. Dermatofibrosarcoma protuberans of the upper lip: an overview and a case report. Eur J Surg Oncol 1997;23:275-7.
112. Gayner SM, Lewis JE, McCaffrey TV. Effect of resection margins on dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol Head Neck Surg 1997;123:430-3.
113. Mark RJ, Bailet JW, Tran LM, et al. Dermatofibrosarcoma protuberans of the head and neck. A report of 16 cases. Arch Otolaryngol Head Neck Surg 1993;119:891-6.
114. Rich JD, Zbylski JR, LaRossa DD. Dermatofibrosarcoma protuberans of the head and neck. Am Surg 1980;46:208-15.
115. Ratner D, Thomas CO, Johnson TM, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997;37:600-13.
116. Parker TL, Zitelli JA. Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1995;32:233-6.
117. Ballo MT, Zagars GK, Pisters P, et al. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 1998;40:823-7.
118. Izumi K, Maeda T, Cheng J, et al. Primary leiomyosarcoma of the maxilla with regional lymph node metastasis: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:310-9.
119. Kuruvilla A, Wenig BM, Humphrey DM, et al. Leiomyosarcoma of the sinonasal tract. A clinicopathologic study of nine cases. Arch Otolaryngol Head Neck Surg 1990; 116:1278-86.
120. Batsakis JG, Jacobs JB, Templeton AC. Hemangiopericytoma of the nasal cavity: electron-optic study and clinical correlations. J Laryngol Otol 1983;97:361-8.
121. Auguste LJ, Razack MS, Sako K. Hemangiopericytoma. J Surg Oncol 1982;20:260-4.
122. Daniels RL, Haller JR, Harnsberger HR. Hemangiopericytoma of the masticator space. Ann Otol Rhinol Laryngol 1996;105:162-5.
123. Pitluk HC, Conn J Jr. Hemangiopericytoma: literature review and clinical presentations. Am J Surg 1979;137:413-6.
124. Sutbeyaz Y, Selimoglu E, Karasen M, et al. Haemangiopericytoma of the middle ear: case report and literature review. J Laryngol Otol 1995;109:977-9.
125. Robb PJ, Singh S, Hartley RB, et al. Malignant hemangiopericytoma of the parapharyngeal space. Head Neck Surg 1987;9:179-83.
126. Bailey PV, Weber TR, Tracy TF Jr, et al. Congenital hemangiopericytoma: an unusual vascular neoplasm of infancy. Surgery 1993;114:936-41.
127. Sabini P, Josephson GD, Yung RT, et al. Hemangiopericytoma presenting as a congenital midline nasal mass. Arch Otolaryngol Head Neck Surg 1998;124:202-4.
128. del Rosario ML, Saleh A. Preoperative chemotherapy for congenital hemangiopericytoma and a review of the literature. J Pediatr Hematol Oncol 1997;19:247-50.
129. Volpe AG, Sullivan JG, Chong FK. Aggressive malignant hemangiopericytoma in the neck. J Surg Oncol 1991;47:136-8.
130. Enzinger FM, Smith BH. Hemangiopericytoma: an analysis of 106 cases. Hum Pathol 1976;7:61-82.
131. McMaster MJ, Soule EH, Ivins JC. Hemangiopericytoma. A clinicopathologic study and long-term followup of 60 patients. Cancer 1975;36:2232-44.
132. Bailet JW, Abemayor E, Andrews JC, et al. Malignant nerve sheath tumors of the head and neck: a combined experience from two university hospitals. Laryngoscope 1991;101:1044-9.
133. Hoffmann DF, Everts EC, Smith JD, et al. Malignant nerve sheath tumors of the head and neck. Otolaryngol Head Neck Surg 1988;99:309-14.
134. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.
135. Russell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977;40:1562-70.
136. Greager JA, Reichard KW, Campana JP, et al. Malignant schwannoma of the head and neck. Am J Surg 1992;163:440-2.
137. al-Otieschan AA, Saleem M, Manohar MB, et al. Malignant schwannoma of the parapharyngeal space. J Laryngol Otol 1998;112:883-7.
138. Golledge J, Fisher C, Rhys-Evans PH. Head and neck liposarcoma. Cancer 1995; 76:1051-8.
139. Dahl EC, Hammond HL, Sequeira E. Liposarcomas of the head and neck. J Oral Maxillofac Surg 1982;40:674-7.
140. McCulloch TM, Makielski KH, McNutt MA. Head and neck liposarcoma: a histopathologic reevaluation of reported cases. Arch Otolaryngol Head Neck Surg 1992; 118:1045-9.
141. Saunders JR, Jaques DA, Casterline PF, et al. Liposarcomas of the head and neck: a review of the literature and addition of four cases. Cancer 1979;43:162-8.
142. Stewart MG, Schwartz MR, Alford BR. Atypical and malignant lipomatous lesions of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:1151-5.
143. Enzinger F, Winslow D. Liposarcoma: a study of 103 cases. Virchows Arch Path Anat 1962;335:367-88.
144. Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999;85:85-92.
145. Carrillo R, Rodriguez-Peralto JL, Batsakis JG. Synovial sarcomas of the head and neck. Ann Otol Rhinol Laryngol 1992;101:367-70.
146. Cihak RA, Lydiatt WM, Lydiatt DD, et al. Synovial sarcoma of the head and neck: chromosomal translation (X;18) as a diagnostic aid. Head Neck 1997;19:549-53.
147. Bridge JA, Bridge RS, Borek DA, et al. Translocation t(X;18) in orofacial synovial sarcoma. Cancer 1988;62:935-7.
148. Kawai A, Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998;338:153-60.
149. Turc-Carel C, Dal Cin P, Limon J, et al. Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet 1986;23:93.
150. Bukachevsky RP, Pincus RL, Shechtman FG, et al. Synovial sarcoma of the head and neck. Head Neck 1992;14:44-8.
151. Mamelle G, Richard J, Luboinski B, et al. Synovial sarcoma of the head and neck: an account of four cases and review of the literature. Eur J Surg Oncol 1986;12:347-9.
152. Amble FR, Olsen KD, Nascimento AG, et al. Head and neck synovial cell sarcoma. Otolaryngol Head Neck Surg 1992;107:631-7.
153. Doval DC, Kannan V, Mukherjee G, et al. Synovial sarcoma of the neck. Eur Arch Otorhinolaryngol 1997;254:246-50.
154. Miloro M, Quinn PD, Stewart JC. Monophasic spindle cell synovial sarcoma of the head and neck: report of two cases and review of the literature. J Oral Maxillofac Surg 1994;52:309-13.
155. Ramamurthy L, Nassar WY, Hasleton PS, et al. Synovial sarcoma of the pharynx. J Laryngol Otol 1995;109:1207-10.
156. Sneige N, Batsakis JG. Ewing's sarcoma of bone and soft tissues. Ann Otol Rhinol Laryngol 1989;98:400-2.
157. Batsakis JG, Mackay B, el-Naggar AK. Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an interim report. Ann Otol Rhinol Laryngol 1996;105:838-43.
158. Raney RB, Asmar L, Newton WA Jr, et al. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997;15:574-82.
159. Lim TC, Tan WT, Lee YS. Congenital extraskeletal Ewing's sarcoma of the face: a case report. Head Neck 1994;16:75-8.
160. Pagani A, Fischer-Colbrie R, Eder U, et al. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines: morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer 1995;63:738-43.
161. Foschini MP, Eusebi V. Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma? Semin Diagn Pathol 1994;11:58-68.
162. van Echten J, van den Berg E, van Baarlen J, et al. An important role for chromosome 17, band q25, in the histogenesis of alveolar soft part sarcoma. Cancer Genet Cytogenet 1995;82:57-61.
163. Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma: a clinicopathologic study of half a century. Cancer 1989;63:1-13.
164. Batsakis JG. Alveolar soft-part sarcoma. Ann Otol Rhinol Laryngol 1988;97:328-9.
165. Donald PJ. Alveolar soft part sarcoma of the tongue. Head Neck Surg 1987;9:172-8
166. Hunter BC, Devaney KO, Ferlito A, et al. Alveolar soft part sarcoma of the head and neck region. Ann Otol Rhinol Laryngol 1998;107:810-4.
167. Iwamoto Y, Morimoto N, Chuman H, et al. The role of MR imaging in the diagnosis of alveolar soft part sarcoma: a report of 10 cases. Skeletal Radiol 1995;24:267-70.
168. Cetik F, Ozsahinoglu C, Kivanc F, et al. Alveolar soft part sarcoma of the tongue. J Laryngol Otol 1989;103:952-4.
169. Rubinstein MI, Drake AF, McClatchey KD. Alveolar soft part sarcoma of the nasal cavity: report of a case and a review of the literature. Laryngoscope 1988;98:1246-50.
170. Portera CA Jr, Ho V, Patel SR, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 2001;91:585-91.
171. Browne JD. Management of nonepidermoid cancer of the larynx. Otolaryngol Clin North Am 1997;30:215-29.
172. Farrell ML, Gluckman JL, Biddinger P. Tracheal chondrosarcoma: a case report. Head Neck 1998;20:568-72.
173. Burkey BB, Hoffman HT, Baker SR, et al. Chondrosarcoma of the head and neck. Laryngoscope 1990;100:1301-5.
174. Finn DG, Goepfert H, Batsakis JG. Chondrosarcoma of the head and neck. Laryngoscope 1984;94:1539-44.
175. Mark RJ, Tran LM, Sercarz J, et al. Chondrosarcoma of the head and neck: the UCLA experience, 1955-1988. Am J Clin Oncol 1993;16:232-7.
176. Ruark DS, Schlehaider UK, Shah JP. Chondrosarcomas of the head and neck. World J Surg 1992;16:1010-5; discussion, 1015-6.
177. Rapidis AD, Archondakis G, Anteriotis D, et al. Chondrosarcomas of the skull base: review of the literature and report of two cases. J Craniomaxillofac Surg 1997;25:322-7.
178. Gadwal SR, Fanburg-Smith JC, Gannon FH, et al. Primary chondrosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 14 cases with a review of the literature. Cancer 2000;88:2181-8.
179. Langstein HN, Robb GL. Reconstructive approaches in soft tissue sarcoma. Semin Surg Oncol 1999;17:52-65.
180. Cakir S, Dincbas FO, Uzel O, et al. Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiother Oncol 1995;37:10-6.
181. Greager JA, Patel MK, Briele HA, et al. Soft tissue sarcomas of the adult head and neck. Cancer 1985;56:820-4.
182. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20:791-6.
183. Meyers P. Prognostic factors for sarcomas: hard and soft. J Clin Oncol 2002:20:627-9.